Carmell Therapeutics Merges with Axolotl Biologix

Carmell Therapeutics executed a definitive agreement and plan of merger with Axolotl Biologix, a regenerative medicine company developing human amnion-based allograft products for active soft tissue repair, orthopedic and other indications.

Axolotl Biologix offers regenerative medicine treatment applications with clinical benefits found to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us